S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
TSLA   335.89 (+1.67%)
AMD   39.63 (+0.03%)
BAC   33.67 (+1.75%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
TSLA   335.89 (+1.67%)
AMD   39.63 (+0.03%)
BAC   33.67 (+1.75%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
TSLA   335.89 (+1.67%)
AMD   39.63 (+0.03%)
BAC   33.67 (+1.75%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
TSLA   335.89 (+1.67%)
AMD   39.63 (+0.03%)
BAC   33.67 (+1.75%)
Log in

NASDAQ:SRRK - Scholar Rock Stock Price, Forecast & News

$8.48
+0.49 (+6.13 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$7.91
Now: $8.48
$8.80
50-Day Range
$7.20
MA: $8.97
$10.58
52-Week Range
$6.95
Now: $8.48
$30.00
Volume261,415 shs
Average Volume103,585 shs
Market Capitalization$251.67 million
P/E RatioN/A
Dividend YieldN/A
Beta0.02
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its lead antibody product candidate is SRK-015, an inhibitor of the activation of myostatin, which is in Phase I clinical trials for the treatment of spinal muscular atrophy. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SRRK
CUSIPN/A
CIKN/A
Phone857-259-3860

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$380,000.00
Book Value$4.22 per share

Profitability

Net Income$-49,330,000.00

Miscellaneous

Employees65
Market Cap$251.67 million
Next Earnings Date3/16/2020 (Estimated)
OptionableNot Optionable

Receive SRRK News and Ratings via Email

Sign-up to receive the latest news and ratings for SRRK and its competitors with MarketBeat's FREE daily newsletter.


Scholar Rock (NASDAQ:SRRK) Frequently Asked Questions

What is Scholar Rock's stock symbol?

Scholar Rock trades on the NASDAQ under the ticker symbol "SRRK."

How were Scholar Rock's earnings last quarter?

Scholar Rock Holding Corp (NASDAQ:SRRK) posted its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.55) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.33) by $0.22. The business had revenue of $4.77 million for the quarter, compared to analyst estimates of $12.73 million. View Scholar Rock's Earnings History.

When is Scholar Rock's next earnings date?

Scholar Rock is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Scholar Rock.

What price target have analysts set for SRRK?

2 brokers have issued twelve-month price targets for Scholar Rock's shares. Their forecasts range from $27.00 to $27.00. On average, they anticipate Scholar Rock's stock price to reach $27.00 in the next year. This suggests a possible upside of 218.4% from the stock's current price. View Analyst Price Targets for Scholar Rock.

What is the consensus analysts' recommendation for Scholar Rock?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Scholar Rock in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Scholar Rock.

Has Scholar Rock been receiving favorable news coverage?

News coverage about SRRK stock has trended somewhat negative this week, InfoTrie reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Scholar Rock earned a daily sentiment score of -1.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Scholar Rock.

Who are some of Scholar Rock's key competitors?

What other stocks do shareholders of Scholar Rock own?

Who are Scholar Rock's key executives?

Scholar Rock's management team includes the folowing people:
  • Mr. Nagesh K. Mahanthappa Ph.D., Pres, CEO & Exec. Director (Age 54)
  • Mr. Yung H. Chyung, Chief Medical Officer (Age 43)
  • Ms. Rhonda M. Chicko, Chief Financial Officer (Age 53)
  • Mr. Alan J. Buckler, Chief Scientific Officer (Age 59)
  • Ms. Catherine Hu, Exec. Director of Investor Relations & Corp. Communications

When did Scholar Rock IPO?

(SRRK) raised $76 million in an initial public offering (IPO) on Thursday, May 24th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. Jefferies, Cowen and BMO Capital Markets acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Who are Scholar Rock's major shareholders?

Scholar Rock's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Redmile Group LLC (9.63%), State Street Corp (1.09%), Squarepoint Ops LLC (0.27%), Alps Advisors Inc. (0.20%), Millennium Management LLC (0.14%) and Alberta Investment Management Corp (0.13%). Company insiders that own Scholar Rock stock include Amir Nashat and International SCA Artal. View Institutional Ownership Trends for Scholar Rock.

Which major investors are selling Scholar Rock stock?

SRRK stock was sold by a variety of institutional investors in the last quarter, including Redmile Group LLC and Barclays PLC. View Insider Buying and Selling for Scholar Rock.

Which major investors are buying Scholar Rock stock?

SRRK stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Millennium Management LLC, Alberta Investment Management Corp, Bowling Portfolio Management LLC, Squarepoint Ops LLC, Public Employees Retirement System of Ohio, Russell Investments Group Ltd. and Alps Advisors Inc.. Company insiders that have bought Scholar Rock stock in the last two years include Amir Nashat and International SCA Artal. View Insider Buying and Selling for Scholar Rock.

How do I buy shares of Scholar Rock?

Shares of SRRK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Scholar Rock's stock price today?

One share of SRRK stock can currently be purchased for approximately $8.48.

How big of a company is Scholar Rock?

Scholar Rock has a market capitalization of $251.67 million and generates $380,000.00 in revenue each year. The company earns $-49,330,000.00 in net income (profit) each year or ($3.15) on an earnings per share basis. Scholar Rock employs 65 workers across the globe.View Additional Information About Scholar Rock.

What is Scholar Rock's official website?

The official website for Scholar Rock is http://www.scholarrock.com/.

How can I contact Scholar Rock?

Scholar Rock's mailing address is 620 MEMORIAL DRIVE 2ND FLOOR, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-259-3860 or via email at [email protected]


MarketBeat Community Rating for Scholar Rock (NASDAQ SRRK)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  125 (Vote Underperform)
Total Votes:  227
MarketBeat's community ratings are surveys of what our community members think about Scholar Rock and other stocks. Vote "Outperform" if you believe SRRK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRRK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel